These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 3270584)

  • 1. Preliminary reports on hyperbaric oxygen therapy in multiple sclerosis.
    Ulewicz K; Dolmierski R; Masłowski J; Michniewski P; Kierznikowicz B; Wisłocka I; Sićko Z; Olszański R
    Bull Inst Marit Trop Med Gdynia; 1988; 39(3-4):197-204. PubMed ID: 3270584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperbaric oxygen therapy in the treatment of multiple sclerosis. A clinical and electrophysiological study in a 2 year follow-up.
    Meneghetti G; Spartà S; Rusca F; Facco E; Martini A; Comacchio F; Schiraldi C
    Riv Neurol; 1990; 60(2):67-71. PubMed ID: 2247750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preliminary research on possibility of bronchial asthma treatment with hyperbaric oxygenation.
    Ulewicz K; Bogetti B; Magno L; Canepari P; Wisłocka I; Raczka A
    Bull Inst Marit Trop Med Gdynia; 1987; 38(1-2):59-68. PubMed ID: 3506436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Double-blind treatment of 49 cases of chronic multiple sclerosis using hyperbaric oxygen].
    Lhermitte F; Roullet E; Lyon-Caen O; Metrot J; Villey T; Bach MA; Tournier-Lasserve E; Chabassol E; Rascol A; Clanet M
    Rev Neurol (Paris); 1986; 142(3):201-6. PubMed ID: 2879344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Thymus-dependent and thymus-independent blood lymphocytes in multiple sclerosis].
    Khondkarian OA; Gannushkina IV; Zavalishin IA; Zhirnova IG; Nevskaia OM
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1983; 83(3):32-6. PubMed ID: 6602442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exposure of multiple sclerosis patients to hyperbaric oxygen at 1.5--2 ATA. A preliminary report.
    Neubauer RA
    J Fla Med Assoc; 1980 May; 67(5):498-504. PubMed ID: 7381413
    [No Abstract]   [Full Text] [Related]  

  • 7. [The dynamics of immunological indicators in the treatment of patients with multiple sclerosis with prednisolone combined with plasmapheresis].
    Neretin VIa; Gannushkina IV; Zhirnova IG; Sapfirova VA; Kir'iakov VA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1988; 88(2):17-21. PubMed ID: 3259769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hyperbaric therapy of multiple sclerosis].
    Pallotta R
    Minerva Med; 1982 Nov; 73(42):2947-54. PubMed ID: 7133505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [40 cases of multiple sclerosis treated with hyperbaric oxygen therapy].
    Zannini D; Formai C; Bogetti B; Sereni G
    Minerva Med; 1982 Nov; 73(42):2939-45. PubMed ID: 7133504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The chief scientist reports ... hyperbaric oxygen for multiple sclerosis patients.
    Webster CJ; MacIver C; Allen S; Murray S
    Health Bull (Edinb); 1989 Nov; 47(6):320-31. PubMed ID: 2592201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of multiple sclerosis with hyperbaric oxygen. Results of a national registry.
    Kindwall EP; McQuillen MP; Khatri BO; Gruchow HW; Kindwall ML
    Arch Neurol; 1991 Feb; 48(2):195-9. PubMed ID: 1993011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Rapid modification of the symptomatology of progressive forms of multiple sclerosis by plasma exchange].
    Trouillas P; Neuschwander P; Trémisi JP
    Rev Neurol (Paris); 1986; 142(8-9):689-95. PubMed ID: 3809855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isoprinosine in multiple sclerosis treatment: a preliminary study.
    Mazzarello P; Rocchelli B; Poloni M; Delodovici M; Pinelli P
    Schweiz Arch Neurol Neurochir Psychiatr; 1982; 131(2):175-9. PubMed ID: 6187064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utilization of the multiple sclerosis functional composite in follow-up: relationship to disease phenotype, disability and treatment strategies.
    Ozakbas S; Ormeci B; Idiman E
    J Neurol Sci; 2005 May; 232(1-2):65-9. PubMed ID: 15850584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Initial experiences with the Reiber 1979 determination of autochthonous IgG production within the scope of clinical and immunologic follow-up studies in multiple sclerosis treated with immunosuppressive therapy].
    Dachsel R; Köppel C
    Psychiatr Neurol Med Psychol (Leipz); 1989 Jul; 41(7):420-5. PubMed ID: 2772076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hyperbaric oxygenation in the combined treatment of disseminated sclerosis patients].
    Ermolenko FM; Ter-Karapetian VA; Donskikh AA
    Vrach Delo; 1987 Aug; (8):91-4. PubMed ID: 3686977
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical aspects of fatigue in multiple sclerosis.
    Bergamaschi R; Romani A; Versino M; Poli R; Cosi V
    Funct Neurol; 1997; 12(5):247-51. PubMed ID: 9439942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical, immunologic and electrophysiologic correlations in evaluating multiple sclerosis in relation to its development].
    Cazzullo CL; Montanini R; Ghezzi A; Zaffaroni M; Giussani D; Loner R; Caputo D; Marforio S; Zibetti A
    Minerva Med; 1984 Nov; 75(43):2585-9. PubMed ID: 6392935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Reconsidering fatigue at the onset of multiple sclerosis].
    Debouverie M; Pittion-Vouyovitch S; Guillemin F
    Rev Neurol (Paris); 2009 Mar; 165 Suppl 4():S135-44. PubMed ID: 19361678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and MRI correlates of autoreactive antibodies in multiple sclerosis patients.
    Garg N; Zivadinov R; Ramanathan M; Vasiliu I; Locke J; Watts K; Lema J; Rajeswary J; Munschauer FE; Ambrus J; Weinstock-Guttman B
    J Neuroimmunol; 2007 Jul; 187(1-2):159-65. PubMed ID: 17512610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.